UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group

Leukemia, 2017-12, Vol.31 (12), p.2833-2837

2017

Volltextzugriff (PDF)

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL

Hematological oncology, 2023-06, Vol.41 (S2), p.56-58

2023

Volltextzugriff (PDF)

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CLL: PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE‐BLIND RANDOMIZED CLL12 TRIAL

Hematological oncology, 2019-06, Vol.37 (S2), p.38-40

2019

Volltextzugriff (PDF)

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines

Annals of oncology, 2008-05, Vol.19 (5), p.871-876

2008

Volltextzugriff (PDF)

Knowledge and experience of palliative medicine among general practitioners in Germany

Deutsche medizinische Wochenschrift (1946), 2007-12, Vol.132 (49), p.2620

2007

Volltextzugriff (PDF)

Palliativmedizinische Erfahrungen deutscher Hausärzte

Deutsche medizinische Wochenschrift, 2007-12, Vol.132 (49), p.2620-2623

2007

Volltextzugriff (PDF)

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Clinical lymphoma, myeloma and leukemia, 2018-10, Vol.18 (10), p.e401-e419

2018

Volltextzugriff (PDF)

Palliativmedizinische Erfahrungen deutscher Hausärzte

Deutsche medizinische Wochenschrift, 2007-12, Vol.132 (49), p.2620-2623

2007

Volltextzugriff (PDF)

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Hematological oncology, 2023-06, Vol.41 Suppl 2, p.56

2023

Volltextzugriff (PDF)

9210 Bendamustine vs. fludarabine as second-line treatment in chronic lymphocytic leukemia

European journal of cancer supplements, 2009, Vol.7 (2), p.563-563

2009

Volltextzugriff (PDF)

Ambulante palliativmedizinischeBetreuung von Tumorpatienten

Best practice onkologie, 2007-08, Vol.2 (4), p.46-54

2007

Volltextzugriff (PDF)

Ambulante palliativmedizinische Betreuung von Tumorpatienten: Aus dem Blickwinkel des Klinikers und des niedergelassenen Onkologen

Best practice onkologie, 2007-08, Vol.2 (4), p.46-54

2007

Volltextzugriff (PDF)

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study

Clinical epidemiology, 2015-01, Vol.7 (default), p.295-303

2015

Volltextzugriff (PDF)

1487PDINTRAPERITONEAL BEVACIZUMAB (BEV) FOR CONTROL OF MALIGNANT ASCITES DUE TO ADVANCED-STAGE GASTROINTESTINAL CANCERS (GI): A MULTICENTER DOUBLE-BLIND, PLACEBO (PL)-CONTROLLED, RANDOMIZED PHASE II STUDY. AIO SUP-0108

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv520-iv520

2014

Volltextzugriff (PDF)

Intraperitoneal Bevacizumab (Bev) for Control of Malignant Ascites Due to Advanced-Stage Gastrointestinal Cancers (Gi): a Multicenter Double-Blind, Placebo (Pl)-Controlled, Randomized Phase Ii Study. Aio Sup-0108

Annals of oncology, 2014-09, Vol.25, p.iv520

2014

Volltextzugriff (PDF)

835PUPDATED OS ANALYSIS, MULTIVARIATE AND QTWIST ANALYSIS OF A RANDOMIZED SEQUENTIAL OPEN-LABEL STUDY (SWITCH) TO EVALUATE EFFICACY AND SAFETY OF SORAFENIB (SO) / SUNITINIB (SU) VERSUS SU/SO IN THE TREATMENT OF METASTATIC RENAL CELL CANCER (MRCC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv290-iv290

2014

Volltextzugriff (PDF)

Typische palliativmedizinische Behandlungsmuster in den häufigsten Tumorentitäten

Zeitschrift für Palliativmedizin, 2005, Vol.6 (1)

2005

Volltextzugriff (PDF)

Randomised trial comparing gemcitabine plus vinorelbine (Gem/Vin), gemcitabine plus cisplatin (Gem/Cis), and gemcitabine plus capecitabine (Gem/Cap) in pretreated metastatic breast cancer (MBC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1054-1054

2008

Volltextzugriff (PDF)

Activity of the combination of bevacizumab (Bev) with capecitabine/irinotecan (CapIri/Bev) or capecitabine/oxaliplatin (CapOx/Bev) in advanced colorectal cancer (ACRC): A randomized phase II study of the AIO Colorectal Study Group (AIO trial 0604)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.4030-4030

2008

Volltextzugriff (PDF)

Bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines: Final results of a phase I/II study

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.1072-1072

2007

Volltextzugriff (PDF)

Comparable safety and response rate with bevacizumab in combination with capecitabine/oxaliplatin (CapOx/Bev) versus capecitabine/irinotecan (CapIri/Bev) in advanced CRC (mCRC): A randomized phase II study of the AIO GI tumor study group

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.4034-4034

2007

Volltextzugriff (PDF)

Identification of strategies and chronometric analysis of problem solving processes

1978, 2022, Vol.186, Heft 1, p.70-74

2022

Volltextzugriff (PDF)

Phase I trial of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.755-755

2005

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Englisch
(162)
Deutsch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Humans
(46)
Life Sciences & Biomedicine
(45)
Physical Sciences
(29)
Physics
(24)
Biological And Medical Sciences
(22)
Female
(21)
Male
(17)
Animals
(15)
Energy Range
(14)
Medical Sciences
(13)
Physics, Multidisciplinary
(13)
Fundamental And Applied Biological Sciences. Psychology
(10)
Measured Values
(9)
Adolescent
(8)
Child
(8)
Energy
(8)
Angular Distribution
(7)
Cross Sections
(7)
Nuclear Emulsions
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAïVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE CLL12 TRIAL

IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CLL: PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE‐BLIND RANDOMIZED CLL12 TRIAL

A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines

Knowledge and experience of palliative medicine among general practitioners in Germany

Palliativmedizinische Erfahrungen deutscher Hausärzte

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Palliativmedizinische Erfahrungen deutscher Hausärzte

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

9210 Bendamustine vs. fludarabine as second-line treatment in chronic lymphocytic leukemia

Ambulante palliativmedizinischeBetreuung von Tumorpatienten

Ambulante palliativmedizinische Betreuung von Tumorpatienten: Aus dem Blickwinkel des Klinikers und des niedergelassenen Onkologen

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study

1487PDINTRAPERITONEAL BEVACIZUMAB (BEV) FOR CONTROL OF MALIGNANT ASCITES DUE TO ADVANCED-STAGE GASTROINTESTINAL CANCERS (GI): A MULTICENTER DOUBLE-BLIND, PLACEBO (PL)-CONTROLLED, RANDOMIZED PHASE II STUDY. AIO SUP-0108

Intraperitoneal Bevacizumab (Bev) for Control of Malignant Ascites Due to Advanced-Stage Gastrointestinal Cancers (Gi): a Multicenter Double-Blind, Placebo (Pl)-Controlled, Randomized Phase Ii Study. Aio Sup-0108

Updated Os Analysis, Multivariate and Qtwist Analysis of a Randomized Sequential Open-Label Study (Switch) to Evaluate Efficacy and Safety of Sorafenib (So) / Sunitinib (Su) Versus Su/So in the Treatment of Metastatic Renal Cell Cancer (Mrcc)

835PUPDATED OS ANALYSIS, MULTIVARIATE AND QTWIST ANALYSIS OF A RANDOMIZED SEQUENTIAL OPEN-LABEL STUDY (SWITCH) TO EVALUATE EFFICACY AND SAFETY OF SORAFENIB (SO) / SUNITINIB (SU) VERSUS SU/SO IN THE TREATMENT OF METASTATIC RENAL CELL CANCER (MRCC)

Typische palliativmedizinische Behandlungsmuster in den häufigsten Tumorentitäten

Randomised trial comparing gemcitabine plus vinorelbine (Gem/Vin), gemcitabine plus cisplatin (Gem/Cis), and gemcitabine plus capecitabine (Gem/Cap) in pretreated metastatic breast cancer (MBC)

Activity of the combination of bevacizumab (Bev) with capecitabine/irinotecan (CapIri/Bev) or capecitabine/oxaliplatin (CapOx/Bev) in advanced colorectal cancer (ACRC): A randomized phase II study of the AIO Colorectal Study Group (AIO trial 0604)

Bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines: Final results of a phase I/II study

Comparable safety and response rate with bevacizumab in combination with capecitabine/oxaliplatin (CapOx/Bev) versus capecitabine/irinotecan (CapIri/Bev) in advanced CRC (mCRC): A randomized phase II study of the AIO GI tumor study group

Identification of strategies and chronometric analysis of problem solving processes

Phase I trial of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines

Aktive Filter

Suchergebnisse filtern